SCHIMMEL PAUL
Insider CIK 1236447 · ALNY Director · LIFE Director · TOCA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATYR aTYR PHARMA INC | P Buy | 2026-05-27 | 2026-05-28 | 100,000 | $0.50 | $50.0K | 779,143 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2026-05-11 | 2026-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2025-10-09 | 2025-10-09 | 317,999 | $0.94 | $298.9K | 1,413,023 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2025-10-08 | 2025-10-09 | 682,001 | $0.90 | $613.8K | 1,095,024 | SEC↗ |
| ATYR aTYR PHARMA INC | A Award deriv | 2025-05-01 | 2025-05-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2024-07-24 | 2024-07-24 | 52,300 | $1.93 | $100.9K | 413,023 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2024-07-23 | 2024-07-24 | 6,648 | $1.82 | $12.1K | 360,723 | SEC↗ |
| ATYR aTYR PHARMA INC | P Buy | 2024-07-22 | 2024-07-24 | 41,052 | $1.74 | $71.4K | 354,075 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2024-05-22 | 2024-05-23 | 24,000 | — | $0 | 24,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2023-05-17 | 2023-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2023-05-10 | 2023-05-11 | 200,000 | $2.25 | $450.0K | 313,023 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise deriv | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | M Exercise | 2023-04-26 | 2023-04-28 | 6,000 | — | $0 | 8,890 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2022-04-26 | 2022-04-28 | 6,000 | — | $0 | 6,000 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2021-09-20 | 2021-09-22 | 250,000 | — | $0 | 679,143 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2021-09-20 | 2021-09-22 | 250,000 | $8.00 | $2.00M | 252,890 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2021-09-20 | 2021-09-22 | 250,000 | — | $0 | 2,890 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2021-05-18 | 2021-05-20 | 50,000 | $3.98 | $199.0K | 113,023 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2021-04-28 | 2021-04-29 | 1,428 | — | $0 | 1,428 | SEC↗ |
| LIFE aTYR PHARMA INC | S Sale | 2020-05-20 | 2020-05-22 | 8,447 | $3.64 | $30.7K | 429,143 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2020-05-06 | 2020-05-08 | 1,428 | — | $0 | 1,428 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2020-02-10 | 2020-02-11 | 254,000 | $4.25 | $1.08M | 437,590 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-10-04 | 2019-10-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2019-05-29 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2019-05-08 | 2019-05-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award | 2019-04-12 | 2019-04-16 | 1,848,428 | $0.54 | $998.2K | 2,570,242 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-11-26 | 2018-11-28 | 147,225 | $0.54 | $79.5K | 882,302 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-09-04 | 2018-09-05 | 20,749 | $0.76 | $15.8K | 735,077 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-08-31 | 2018-09-05 | 22,000 | $0.72 | $15.8K | 714,328 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-08-30 | 2018-08-31 | 89,275 | $0.76 | $67.8K | 692,328 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-08-29 | 2018-08-31 | 75,136 | $0.72 | $54.1K | 603,053 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2018-06-21 | 2018-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2018-05-18 | 2018-05-21 | 150,000 | $1.00 | $150.0K | 527,917 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2018-05-15 | 2018-05-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 2,823 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-03-13 | 2018-03-14 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 10,000 | $30.09 | $300.9K | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-03-13 | 2018-03-14 | 27,823 | $150.00 | $4.17M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 2,823 | $63.86 | $180.3K | 12,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-03-13 | 2018-03-14 | 15,000 | $59.25 | $888.8K | 27,823 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy deriv | 2017-08-31 | 2017-09-05 | 35,376 | — | $0 | 35,376 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2017-08-31 | 2017-09-05 | 94,336 | $2.65 | $250.0K | 377,917 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TOCA Tocagen Inc | C Conversion deriv | 2017-04-19 | 2017-04-21 | 161,906 | — | $0 | 0 | SEC↗ |
| TOCA Tocagen Inc | C Conversion deriv | 2017-04-19 | 2017-04-21 | 25,000 | — | $0 | 0 | SEC↗ |
| TOCA Tocagen Inc | C Conversion deriv | 2017-04-19 | 2017-04-21 | 28,410 | — | $0 | 0 | SEC↗ |
| TOCA Tocagen Inc | C Conversion deriv | 2017-04-19 | 2017-04-21 | 25,000 | — | $0 | 0 | SEC↗ |
| TOCA Tocagen Inc | P Buy | 2017-04-19 | 2017-04-21 | 10,000 | $10.00 | $100.0K | 13,623 | SEC↗ |
| TOCA Tocagen Inc | C Conversion | 2017-04-19 | 2017-04-21 | 3,623 | — | $0 | 3,623 | SEC↗ |
| TOCA Tocagen Inc | C Conversion | 2017-04-19 | 2017-04-21 | 3,623 | — | $0 | 3,623 | SEC↗ |
| TOCA Tocagen Inc | C Conversion | 2017-04-19 | 2017-04-21 | 4,117 | — | $0 | 4,117 | SEC↗ |
| TOCA Tocagen Inc | C Conversion | 2017-04-19 | 2017-04-21 | 23,464 | — | $0 | 23,464 | SEC↗ |
| TOCA Tocagen Inc | A Award deriv | 2017-04-12 | 2017-04-12 | 4,528 | — | $0 | 4,528 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-12-21 | 2016-12-22 | 10,000 | $2.28 | $22.8K | 721,814 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-12-20 | 2016-12-22 | 15,000 | $2.27 | $34.0K | 711,814 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-12-16 | 2016-12-19 | 10,000 | $2.40 | $24.0K | 696,814 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-12-15 | 2016-12-19 | 40,000 | $2.50 | $100.0K | 686,814 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2016-09-23 | 2016-12-19 | 12,572 | — | $0 | 646,814 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2016-09-23 | 2016-12-19 | 12,572 | — | $0 | 40,440 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-14 | 2016-04-15 | 33,619 | $4.22 | $141.9K | 283,581 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-14 | 2016-04-15 | 32,600 | $4.14 | $135.0K | 53,012 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-13 | 2016-04-14 | 9,835 | $3.85 | $37.9K | 249,962 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-12 | 2016-04-13 | 6,546 | $3.70 | $24.2K | 240,127 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-12 | 2016-04-13 | 2,581 | $3.75 | $9.7K | 20,412 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-11 | 2016-04-12 | 27,359 | $3.59 | $98.2K | 214,931 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-11 | 2016-04-12 | 5,300 | $3.45 | $18.3K | 220,231 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-11 | 2016-04-13 | 22,100 | $3.59 | $79.3K | 233,581 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-11 | 2016-04-13 | 5,300 | $3.45 | $18.3K | 211,481 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-11 | 2016-04-13 | 5,259 | $3.59 | $18.9K | 17,831 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-08 | 2016-04-11 | 85,000 | $3.22 | $273.7K | 187,572 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-07 | 2016-04-08 | 40,000 | $3.19 | $127.6K | 102,572 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-06 | 2016-04-07 | 25,000 | $3.20 | $80.0K | 62,572 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2016-04-05 | 2016-04-06 | 25,000 | $3.52 | $88.0K | 37,572 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2015-11-19 | 2015-12-22 | 4,000 | — | $0 | 306,996 | SEC↗ |
| LIFE aTYR PHARMA INC | G Gift | 2015-09-16 | 2016-01-29 | 11,925 | — | $0 | 634,242 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-07-08 | 2015-07-10 | 6,286 | — | $0 | 6,286 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 15,031 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 446,827 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 558,508 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,440,058 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,200,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 525,000 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 248,024 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 470,020 | — | $0 | 600,015 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 31,181 | — | $0 | 31,181 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 46,152 | — | $0 | 646,167 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-04-21 | 2015-04-23 | 5,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-04-21 | 2015-04-23 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-04-21 | 2015-04-23 | 5,000 | $27.28 | $136.4K | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-04-21 | 2015-04-23 | 5,000 | $30.09 | $150.4K | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-04-21 | 2015-04-23 | 10,000 | $130.02 | $1.30M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-03-19 | 2015-03-19 | 9,053 | — | $0 | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-03-19 | 2015-03-19 | 9,053 | $27.28 | $247.0K | 9,053 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-19 | 2015-03-19 | 9,053 | $120.00 | $1.09M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-03-17 | 2015-03-19 | 947 | — | $0 | 14,053 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-03-17 | 2015-03-19 | 947 | $120.00 | $113.6K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-03-17 | 2015-03-19 | 947 | $27.28 | $25.8K | 947 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-08 | 2014-12-10 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-08 | 2014-12-10 | 15,000 | $22.09 | $331.4K | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-08 | 2014-12-10 | 15,000 | $105.00 | $1.57M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-10-28 | 2014-10-30 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-10-28 | 2014-10-30 | 15,000 | $95.00 | $1.43M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-10-28 | 2014-10-30 | 15,000 | $15.91 | $238.7K | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-06-05 | 2014-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-01-13 | 2014-01-14 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-01-13 | 2014-01-14 | 15,000 | $85.36 | $1.28M | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-01-13 | 2014-01-14 | 15,000 | $15.82 | $237.3K | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-01-02 | 2014-01-03 | 2,823 | — | $0 | 2,823 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2013-12-26 | 2014-01-03 | 1,750 | — | $0 | 310,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | G Gift | 2013-12-26 | 2014-01-03 | 1,750 | — | $0 | 312,746 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-20 | 2013-12-23 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-20 | 2013-12-23 | 15,000 | $11.33 | $169.9K | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-20 | 2013-12-23 | 15,000 | $65.00 | $975.0K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-10-22 | 2013-10-24 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-10-22 | 2013-10-24 | 15,000 | $60.00 | $900.0K | 126,216 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-10-22 | 2013-10-24 | 15,000 | $9.30 | $139.5K | 141,216 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-06-06 | 2013-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-06-21 | 2012-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2012-02-21 | 2012-02-23 | 93,023 | $10.75 | $1000.0K | 252,111 | SEC↗ |